Recent data indicate dramatic increases in both awareness and use of electronic cigarettes (e-cigarettes) in the USA. Moreover, e-cigarette use is higher among current smokers than former- or never-smokers. This is of considerable public health significance since very little is known about the effects that e-cigarettes have on brain functioning, behavior, and physiology. This P30 application includes two key projects: project 1 will consist of two laboratory-based experiments and project 2 will be a community-based experiment. For the laboratory-based experiments, non-treatment seeking cigarette smokers (N=90/group) will be evaluated after exposure to e-cigarettes (0 or 18 mg) or their own cigarette on three separate visits: This will allow us to directly compare and evaluate e-cigarettes against smokers'preferred brand of cigarettes. In the first experiment (Project 1a), behavioral and physiological responses to smoking cues will be evaluated using virtual reality cues. In addition, this experiment will assess changes in smoking severity via a dual-component self-administration session in conjunction with the CReSS device to assess smoking topography. In the second experiment (Project 1 b), functional magnetic resonance imaging will be used to measure brain responses to general reward, and to pictures of cigarettes and e-cigarettes. In addition, pictures displaying the Surgeon General's messages about cigarette smoking will be shown to evaluate perceptions about adverse health consequences of cigarettes and e-cigarettes. Upon completion of either laboratory-based experiment, all participants will proceed into the community-based study, project 2, in which all individuals (N=180) will be presented with e-cigarettes (18 mg). In this study, participants will visit the clinic once weekly for 4 week as well as 1 month follow-up. Daily assessments will be conducted using ecological momentary assessment (EMA). EMA assessments will include initiation and continuation of e-cigarette use, assessments of changes in use of own cigarettes, and assessments of perceptions, satisfaction and acceptability of e-cigarettes. Additionally, we will evaluate continuation of e-cigarette use a 1-month follow-up.

Public Health Relevance

This P30 application includes two key projects: project 1 will consist of two laboratory-based experiments and projects will be a community-based experiment. The proposed experiments will provide invaluable and detailed data to the FDA on e-cigarette initiation, use, multiple use, and perceptions in cigarette smokers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA125123-08S2
Application #
8642296
Study Section
Special Emphasis Panel (ZRG1-RPHB-K (40))
Program Officer
Shafik, Hasnaa
Project Start
2007-07-01
Project End
2015-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
8
Fiscal Year
2014
Total Cost
$575,470
Indirect Cost
$203,060
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Yin, Jiani; Chen, Wu; Chao, Eugene S et al. (2018) Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome. Am J Hum Genet 102:296-308
Jones, Kathryn; Versteeg, Leroy; Damania, Ashish et al. (2018) Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease. Infect Immun 86:
Madan, Simran; Kron, Bettina; Jin, Zixue et al. (2018) Arginase overexpression in neurons and its effect on traumatic brain injury. Mol Genet Metab 125:112-117
Kornberg, Michael D; Bhargava, Pavan; Kim, Paul M et al. (2018) Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360:449-453
Koo, Sue-Jie; Szczesny, Bartosz; Wan, Xianxiu et al. (2018) Pentose Phosphate Shunt Modulates Reactive Oxygen Species and Nitric Oxide Production Controlling Trypanosoma cruzi in Macrophages. Front Immunol 9:202
Hsu, Joanne I; Dayaram, Tajhal; Tovy, Ayala et al. (2018) PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. Cell Stem Cell 23:700-713.e6
Singh, Sunita; Jangid, Rahul K; Crowder, Alyssa et al. (2018) Foxi3 transcription factor activity is mediated by a C-terminal transactivation domain and regulated by the Protein Phosphatase 2A (PP2A) complex. Sci Rep 8:17249
Lulla, Premal D; Hill, LaQuisa C; Ramos, Carlos A et al. (2018) The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma. Clin Adv Hematol Oncol 16:375-386
De Maio, Antonia; Yalamanchili, Hari Krishna; Adamski, Carolyn J et al. (2018) RBM17 Interacts with U2SURP and CHERP to Regulate Expression and Splicing of RNA-Processing Proteins. Cell Rep 25:726-736.e7
Bayrer, James R; Wang, Hongtao; Nattiv, Roy et al. (2018) LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun 9:4055

Showing the most recent 10 out of 991 publications